Implementation study of lipid management of high-risk cardiovascular patients- Semmelweis Lipid Center for high-risk patients
Latest Information Update: 19 Apr 2023
Price :
$35 *
At a glance
- Drugs Inclisiran (Primary)
- Indications Coronary artery disease; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms SLICK
- 19 Apr 2023 New trial record